13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 29087466 | Concerted mass spectrometry-based glycomic approach for precision mapping of sulfo sialylated N-glycans on human peripheral blood mononuclear cells and lymphocytes. | 2018 Dec 1 | 1 |
2 | 29475939 | The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling. | 2018 Apr 13 | 1 |
3 | 29619343 | Alterations of the Human Skin N- and O-Glycome in Basal Cell Carcinoma and Squamous Cell Carcinoma. | 2018 | 1 |
4 | 27314244 | Structural and quantitative evidence of α2-6-sialylated N-glycans as markers of the differentiation potential of human mesenchymal stem cells. | 2017 Dec | 4 |
5 | 26721331 | Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer. | 2016 Aug | 1 |
6 | 25556450 | ST6Gal-I predicts postoperative clinical outcome for patients with localized clear-cell renal cell carcinoma. | 2014 | 2 |
7 | 22246380 | One-step immunopurification and lectinochemical characterization of the Duffy atypical chemokine receptor from human erythrocytes. | 2012 Apr | 1 |
8 | 21550977 | Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. | 2011 Jul 1 | 1 |
9 | 21859949 | Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells. | 2011 Nov | 1 |
10 | 18199532 | alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. | 2008 Jan 15 | 2 |
11 | 16897185 | Preferential reduction of the alpha-2-6-sialylation from cell surface N-glycans of human diploid fibroblastic cells by in vitro aging. | 2006 Jul | 1 |
12 | 14514717 | N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits. | 2004 Jan | 1 |
13 | 12637583 | Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. | 2003 May 30 | 1 |